The most recent Credo Award and Five Pillar Leader Award winners were announced at this week’s Clinical Enterprise Leadership Assembly at Langford Auditorium. The awards are conferred on a quarterly basis.
Sandy Bledsoe, vice president, Office of Risk and Insurance Management, received the Five Pillar Leader Award, given for leadership in service, quality, employee engagement, growth and finance, and innovation.
Bledsoe’s nomination letter read, “Sandy represents the best of Vanderbilt and embodies essentially everything we aspire to be. She is on the frontline of essentially every potentially adverse patient care event that happens anywhere in the Medical Center. In that role, she objectively evaluates and then helps lead the Medical Center’s response. Sandy provides invaluable support and advice to everyone. She is honest, compassionate and supportive. She moves seamlessly from objective assessor to a supportive and nurturing advisor. Sandy’s leadership is the ultimate combination of a lawyer, psychiatrist, mother, best friend and objective professional. She is a unique treasure who exemplifies all Credo behaviors.”
Credo Awards honor employees who exemplify the Vanderbilt University Medical Center Credo. The latest Credo Award winners are Jamye O’Neal, laboratory manager for Vanderbilt-Ingram Cancer Center’s Innovative Translational Research Shared Resource; and Richard (Rick) Malone, Pharm.D., MHA, program director for the Investigational Drug Service, in the Department of Pharmaceutical Services.
O’Neal’s nomination read, “Jamye is not satisfied with ‘good enough.’ From workflow to standard operating procedures to budgets and services rates, Jamye tackles difficult issues head-on, and she takes the initiative and ownership to resolve them consistently. Her effective written and oral communications have resulted in a successful new service line for the laboratory and successful clinical trials for VICC oncologists. Her efforts have aided seven successful clinical trial correlative studies, and her “best practices” have put the laboratory in the position to work with oncologists on sponsored trials. Her commitment to her oncology colleagues, the CTSR team, and the success of the laboratory is impressive.”
Malone’s nomination read, “Rick is often called upon to assist when principal investigators are struggling to navigate the bureaucracy of the Food and Drug Administration (FDA) to complete and obtain an Investigational New Drug Application for new studies. Rick is a tremendous asset to these researchers because of his intimate knowledge of FDA rules and regulations and his experience as a member of the Vanderbilt Institutional Review Board (IRB) Committee. In short, Rick and his team ensure that every regulatory and compliance process is strictly adhered to in order to protect patients, investigators and the reputation of Vanderbilt as a world-class research institution.”
